Barclays »

Intellia Therapeutics shares owned by Barclays

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by Barclays

Quarter filed Position value Share count Share price at filing
2023-12-31 $14M 467k 30.49
2023-09-30 $8.1M 257k 31.50
2023-06-30 $9.1M 223k 40.79
2023-03-31 $8.4M 226k 37.25
2022-12-31 $9.1M 260k 35.00
2022-09-30 $10M 185k 55.96
2022-06-30 $5.5M 107k 51.75
2022-03-31 $7.3M 101k 72.66
2021-12-31 $17M 146k 118.24
2021-09-30 $17M 129k 134.17
2021-06-30 $25M 153k 161.89
2021-03-31 $16M 202k 80.25
2020-12-31 $929k 17k 54.40
2020-09-30 $597k 30k 19.87
2020-06-30 $632k 30k 21.04
2020-03-31 $320k 26k 12.23
2019-12-31 $668k 46k 14.68
2019-09-30 $260k 20k 13.31
2019-06-30 $413k 25k 16.36
2019-03-31 $162k 9.5k 17.04
2018-12-31 $209k 15k 13.66
2018-09-30 $466k 16k 28.59
2018-06-30 $205k 7.5k 27.46
2018-03-31 $417k 20k 21.06
2017-12-31 $179k 9.3k 19.24
2017-09-30 $172k 6.9k 24.83
2017-06-30 $0 2.1k 0.00
2017-03-31 $269k 19k 14.24
2016-12-31 $150k 11k 13.37
2016-09-30 $1.0k 68 14.93
2016-06-30 $10k 490 20.41